Skip to content

INOVIO PHARMACEUTICALS, INC.: 10-K filed 2019-03-12

What INOVIO PHARMACEUTICALS, INC. reported in its annual report filed 2019-03-12 (fiscal FY 2018): 50 published measures, 203 facts as tagged in accession 0001055726-19-000012.

This filing

Form
10-K (annual report)
Filed
2019-03-12
Fiscal period
fiscal FY 2018
Accession
0001055726-19-000012 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INOVIO PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-12-31131,113,265USD
At 2017-12-31187,239,270USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2018-12-3144,080,858USD
At 2017-12-3144,750,461USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-12-3186,936,138USD
At 2017-12-31142,392,540USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2018-12-3123,693,633USD
At 2017-12-3123,786,579USD
At 2016-12-3119,136,472USD
At 2015-12-3157,632,693USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2018-01-01 to 2018-12-31-96,967,830USD365
2017-01-01 to 2017-12-31-88,205,772USD365
2016-01-01 to 2016-12-31-73,740,339USD366

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2018-01-01 to 2018-12-31-73,550,156USD365
2017-01-01 to 2017-12-31-63,208,921USD365
2016-01-01 to 2016-12-31-62,555,052USD366

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2018-01-01 to 2018-12-312,085,022USD365
2017-01-01 to 2017-12-3110,293,902USD365
2016-01-01 to 2016-12-312,738,470USD366

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2018-10-01 to 2018-12-312,502,624USD92
2018-01-01 to 2018-12-3130,481,897USD365
2018-07-01 to 2018-09-302,000,868USD92
2018-04-01 to 2018-06-3024,448,761USD91
2018-01-01 to 2018-03-311,529,644USD90
2017-10-01 to 2017-12-318,787,234USD92
2017-01-01 to 2017-12-3142,220,086USD365
2017-07-01 to 2017-09-302,644,543USD92
2017-04-01 to 2017-06-3020,412,124USD91
2017-01-01 to 2017-03-3110,376,185USD90
2016-01-01 to 2016-12-3135,368,361USD366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2018-01-01 to 2018-12-3131,037,302USD365
2017-01-01 to 2017-12-3195,690,172USD365
2016-01-01 to 2016-12-317,786,942USD366

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2018-01-01 to 2018-12-3142,419,908USD365
2017-01-01 to 2017-12-31-27,831,144USD365
2016-01-01 to 2016-12-3116,271,889USD366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-12-31-620,426,436USD
At 2018-01-01-523,124,951USD
At 2017-12-31-523,356,317USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2018-01-01 to 2018-12-3192,539,997shares365
2017-01-01 to 2017-12-3181,777,493shares365
2016-01-01 to 2016-12-3173,214,766shares366

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2018-01-01 to 2018-12-3192,539,997shares365
2017-01-01 to 2017-12-3181,918,022shares365
2016-01-01 to 2016-12-3173,214,766shares366

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2018-10-01 to 2018-12-31-0.34USD/shares92
2018-01-01 to 2018-12-31-1.05USD/shares365
2018-07-01 to 2018-09-30-0.27USD/shares92
2018-04-01 to 2018-06-30-0.07USD/shares91
2018-01-01 to 2018-03-31-0.36USD/shares90
2017-10-01 to 2017-12-31-0.24USD/shares92
2017-01-01 to 2017-12-31-1.08USD/shares365
2017-07-01 to 2017-09-30-0.39USD/shares92
2017-04-01 to 2017-06-30-0.13USD/shares91
2017-01-01 to 2017-03-31-0.31USD/shares90
2016-01-01 to 2016-12-31-1.01USD/shares366

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2018-10-01 to 2018-12-31-0.34USD/shares92
2018-01-01 to 2018-12-31-1.05USD/shares365
2018-07-01 to 2018-09-30-0.27USD/shares92
2018-04-01 to 2018-06-30-0.08USD/shares91
2018-01-01 to 2018-03-31-0.36USD/shares90
2017-10-01 to 2017-12-31-0.24USD/shares92
2017-01-01 to 2017-12-31-1.09USD/shares365
2017-07-01 to 2017-09-30-0.4USD/shares92
2017-04-01 to 2017-06-30-0.13USD/shares91
2017-01-01 to 2017-03-31-0.31USD/shares90
2016-01-01 to 2016-12-31-1.01USD/shares366

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2018-10-01 to 2018-12-310USD92
2018-01-01 to 2018-12-312,169,811USD365
2018-07-01 to 2018-09-300USD92
2018-04-01 to 2018-06-300USD91
2018-01-01 to 2018-03-312,169,811USD90
2017-01-01 to 2017-12-310USD365
2016-01-01 to 2016-12-310USD366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2018-12-3115,949,014USD
At 2017-12-3118,320,176USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2018-01-01 to 2018-12-3110,654,622USD365
2017-01-01 to 2017-12-3113,070,962USD365
2016-01-01 to 2016-12-3110,479,135USD366

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2018-10-01 to 2018-12-31-29,499,164USD92
2018-01-01 to 2018-12-31-94,091,138USD365
2018-07-01 to 2018-09-30-26,642,683USD92
2018-04-01 to 2018-06-30-5,203,169USD91
2018-01-01 to 2018-03-31-32,746,122USD90
2017-10-01 to 2017-12-31-22,887,789USD92
2017-01-01 to 2017-12-31-83,642,901USD365
2017-07-01 to 2017-09-30-29,185,471USD92
2017-04-01 to 2017-06-30-9,635,733USD91
2017-01-01 to 2017-03-31-21,933,908USD90
2016-01-01 to 2016-12-31-76,235,937USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-12-3187,814,824USD
At 2017-12-31138,362,160USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2018-12-3135,299,759USD
At 2017-12-3135,405,426USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2018-12-3110,513,371USD
At 2017-12-3110,513,371USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2018-12-314,760,145USD
At 2017-12-316,009,729USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2018-12-313,316,361USD
At 2017-12-316,003,205USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2018-10-01 to 2018-12-3132,001,788USD92
2018-01-01 to 2018-12-31124,573,035USD365
2018-07-01 to 2018-09-3028,643,551USD92
2018-04-01 to 2018-06-3029,651,930USD91
2018-01-01 to 2018-03-3134,275,766USD90
2017-10-01 to 2017-12-3131,675,023USD92
2017-01-01 to 2017-12-31125,862,987USD365
2017-07-01 to 2017-09-3031,830,014USD92
2017-04-01 to 2017-06-3030,047,857USD91
2017-01-01 to 2017-03-3132,310,093USD90
2016-01-01 to 2016-12-31111,604,298USD366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2018-10-01 to 2018-12-3126,365,647USD92
2018-01-01 to 2018-12-3195,257,876USD365
2018-07-01 to 2018-09-3021,851,858USD92
2018-04-01 to 2018-06-3022,462,620USD91
2018-01-01 to 2018-03-3124,577,751USD90
2017-10-01 to 2017-12-3124,641,124USD92
2017-01-01 to 2017-12-3198,572,618USD365
2017-07-01 to 2017-09-3025,510,239USD92
2017-04-01 to 2017-06-3023,878,751USD91
2017-01-01 to 2017-03-3124,542,504USD90
2016-01-01 to 2016-12-3188,712,035USD366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-12-3197,225,810shares
At 2017-12-3190,357,644shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2018-12-31707,794,215USD
At 2017-12-31665,775,504USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2018-12-31-528,867USD
At 2018-01-01-348,371USD
At 2017-12-31-117,005USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2018-12-3187,032,407USD
At 2017-12-31142,488,809USD
At 2016-12-31123,378,420USD
At 2015-12-31175,933,053USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2018-12-3125,948,933USD
At 2017-12-3125,426,733USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2018-12-319,999,919USD
At 2017-12-317,106,557USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2018-12-314,760,145USD
At 2017-12-316,009,729USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2018-12-312,669,998USD
At 2017-12-312,639,354USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2018-12-3187,333USD
At 2017-12-310USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2018-12-315,671,764USD
At 2017-12-318,611,892USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2018-12-311,406,590USD
At 2017-12-312,600,906USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2018-12-31223,577USD
At 2017-12-311,175,353USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2018-12-311,243,000USD
At 2017-12-311,952,000USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

PeriodValueUnitDays
At 2018-12-3124,766USD
At 2017-12-3124,766USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2018-10-01 to 2018-12-31-32,962,205USD92
2018-01-01 to 2018-12-31-94,798,019USD365
2018-07-01 to 2018-09-30-25,015,672USD92
2018-04-01 to 2018-06-30-6,639,125USD91
2018-01-01 to 2018-03-31-30,181,017USD90
2017-01-01 to 2017-12-31-88,205,772USD365
2016-01-01 to 2016-12-31-73,740,339USD366

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2018-10-01 to 2018-12-31-32,962,205USD92
2018-01-01 to 2018-12-31-96,967,830USD365
2018-07-01 to 2018-09-30-25,015,672USD92
2018-04-01 to 2018-06-30-6,639,125USD91
2018-01-01 to 2018-03-31-32,350,828USD90
2017-10-01 to 2017-12-31-21,506,179USD92
2017-01-01 to 2017-12-31-88,205,772USD365
2017-07-01 to 2017-09-30-34,134,570USD92
2017-04-01 to 2017-06-30-9,479,116USD91
2017-01-01 to 2017-03-31-23,085,907USD90
2016-01-01 to 2016-12-31-73,740,339USD366

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2018-01-01 to 2018-12-31-96,967,830USD365
2017-01-01 to 2017-12-31-89,012,591USD365
2016-01-01 to 2016-12-31-73,740,339USD366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2018-10-01 to 2018-12-315,636,141USD92
2018-01-01 to 2018-12-3129,315,159USD365
2018-07-01 to 2018-09-306,791,693USD92
2018-04-01 to 2018-06-307,189,310USD91
2018-01-01 to 2018-03-319,698,015USD90
2017-10-01 to 2017-12-318,033,899USD92
2017-01-01 to 2017-12-3128,290,369USD365
2017-07-01 to 2017-09-306,319,775USD92
2017-04-01 to 2017-06-306,169,106USD91
2017-01-01 to 2017-03-317,767,589USD90
2016-01-01 to 2016-12-3123,892,263USD366

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2018-01-01 to 2018-12-313,747,183USD365
2017-01-01 to 2017-12-311,850,376USD365
2016-01-01 to 2016-12-311,708,498USD366

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2018-01-01 to 2018-12-311,249,584USD365
2017-01-01 to 2017-12-311,618,665USD365
2016-01-01 to 2016-12-311,377,466USD366

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2018-01-01 to 2018-12-312,170,000USD365
2017-01-01 to 2017-12-310USD365
2016-01-01 to 2016-12-310USD366

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2018-01-01 to 2018-12-310USD365
2017-01-01 to 2017-12-310USD365
2016-01-01 to 2016-12-310USD366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2018-01-01 to 2018-12-3129,227,776USD365
2017-01-01 to 2017-12-3194,347,922USD365
2016-01-01 to 2016-12-316,295,761USD366

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-12-31-2,686,844USD365
2017-01-01 to 2017-12-31-9,818,306USD365
2016-01-01 to 2016-12-318,521,899USD366

Inspect the source

Entity
INOVIO PHARMACEUTICALS, INC. / CIK 0001055726
Captured
2026-09-20T05:17:43.559Z
SEC response SHA-256
9bfa830827e08b2d190e6d0b4ce0274a3c0d8852b6e536b16b5cfeadcaa54cf9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001055726.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))